These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 11984800)
1. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS). Smith LM; Anderson JR; Coffin CM Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800 [TBL] [Abstract][Full Text] [Related]
2. Pathologic features of rhabdomyosarcoma before and after treatment: a clinicopathologic and immunohistochemical analysis. Coffin CM; Rulon J; Smith L; Bruggers C; White FV Mod Pathol; 1997 Dec; 10(12):1175-87. PubMed ID: 9436961 [TBL] [Abstract][Full Text] [Related]
3. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group. Meza JL; Anderson J; Pappo AS; Meyer WH; J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036 [TBL] [Abstract][Full Text] [Related]
4. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins. Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749 [TBL] [Abstract][Full Text] [Related]
5. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior. Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604 [TBL] [Abstract][Full Text] [Related]
6. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status. Corao DA; Biegel JA; Coffin CM; Barr FG; Wainwright LM; Ernst LM; Choi JK; Zhang PJ; Pawel BR Pediatr Dev Pathol; 2009; 12(4):275-83. PubMed ID: 18788887 [TBL] [Abstract][Full Text] [Related]
7. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997. Raney RB; Stoner JA; Walterhouse DO; Andrassy RJ; Donaldson SS; Laurie F; Meyer WH; Qualman SJ; Crist WM; Pediatr Blood Cancer; 2004 Jun; 42(7):618-25. PubMed ID: 15127417 [TBL] [Abstract][Full Text] [Related]
8. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications. Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640 [TBL] [Abstract][Full Text] [Related]
9. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines. Kouraklis G; Triche TJ; Wesley R; Tsokos M Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice. van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124 [TBL] [Abstract][Full Text] [Related]
11. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Paner GP; McKenney JK; Epstein JI; Amin MB Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707 [TBL] [Abstract][Full Text] [Related]
12. Rhabdomyosarcomas of the nose and paranasal sinuses: treatment results in 15 cases. Wurm J; Constantinidis J; Grabenbauer GG; Iro H Otolaryngol Head Neck Surg; 2005 Jul; 133(1):42-50. PubMed ID: 16025051 [TBL] [Abstract][Full Text] [Related]
13. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Kumar S; Perlman E; Harris CA; Raffeld M; Tsokos M Mod Pathol; 2000 Sep; 13(9):988-93. PubMed ID: 11007039 [TBL] [Abstract][Full Text] [Related]
14. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype. Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938 [TBL] [Abstract][Full Text] [Related]
16. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538 [TBL] [Abstract][Full Text] [Related]
17. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH; Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997. Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM; J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347 [TBL] [Abstract][Full Text] [Related]
19. [Rhabdomysarcoma and combined treatment in oral and maxillofacial regions]. Feng G; Wang DZ; Zheng GY; He J Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):129-31. PubMed ID: 15190796 [TBL] [Abstract][Full Text] [Related]
20. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications. Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]